About

Optimize your CRISPR Design to Efficiently Power Novel Applications in Drug Discovery, Screening and Therapeutic Development

Whilst the commitment and excitement to CRISPR as a ground-breaking technology continues to rise, there is a compelling need to improve the collective understanding around the functional biology and the mechanism of action of the CRISPR/Cas9 system itself.

As such, the 4th Precision CRISPR Congress Boston will showcase only the most reliable, reputable and cutting-edge data to help you optimize your CRISPR workflows. Ensure the reproducible and accurate application of CRISPR, customized to your research objectives.

United by the common goal of increasing efficiency, optimizing delivery and reducing known off-target effects, the 4th Precision CRISPR Congress will host two distinct tracks in 2018 that will enable the industry to delve deeper into the basic research, synthetic biology and therapeutic applications of CRISPR.

So, whether you are harnessing CRISPR for more predictive preclinical disease models, high throughput screening, drug discovery or pursuing safe, effective and clinically viable CRISPR-based gene and cell therapies, ensure you learn and network with senior industry and academic leaders who are striving to make the precision genome editing possibilities of tomorrow, a therapeutic reality today.

“Speakers all gave excellent presentations – perfect balance of both academic and industry/sponsor viewpoints on leveraging CRISPR technology. I enjoyed the format and structured networking sessions were well thought out. I appreciate the opportunity to connect with experts in this emerging field.” – Attendee at last year’s Precision CRISPR Congress

Our contact details

Venue Details

TBC

About Us

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.